EastWest Bioscience Inc.
HBOSF · OTC
4/30/2022 | |
|---|---|
| Market Cap | $0 |
| - Cash | $0 |
| + Debt | $0 |
| Enterprise Value | $0 |
| Revenue | $0 |
| % Growth | – |
| Gross Profit | $0 |
| % Margin | 71.9% |
| EBITDA | -$0 |
| % Margin | -195.2% |
| Net Income | -$0 |
| % Margin | -218.2% |
| EPS Diluted | -0.004 |
| % Growth | – |
| Operating Cash Flow | -$0 |
| Capital Expenditures | $0 |
| Free Cash Flow | -$0 |